Pure Global
NCT05785117

Vagal Nerve Stimulation as Therapeutic Approach on Metabolic Syndrome

Effect of Non-invasive Auricular Vagal Nerve Stimulation Versus Circuit Weight Training on Nutritional Modulation in Patient With Metabolic Syndrome
Rana Elbanna·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Metabolic Syndrome
Drug/Device/Intervention
Vagal Stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Rana Elbanna
Funder
Cairo University
Location
Giza, Egypt
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2023
End date
May 01, 2023
Enrollment
70 participants
Primary outcome

Emotional eating,Patient satisfaction measures,Cortisol level

Summary

Participants were randomly assigned to two groups prior to their second visit: the Vagus
 nerve stimulation group (VNS) and the circuit training program. The randomization processes
 were conducted in Excel utilizing a random-number generator. Prior to the second visit, each
 participants' target exercise heart rate ranges were determined. Vagus nerve stimulation
 group(VNS) Patients rested on their sides in a sitting position. Following regular
 disinfection of the stimulation locations, ear clips were placed in the ear region (auricular
 concha) at the stimulation site. The training regimen included ten different forms of
 resistance and aerobic exercises.

ICD-10 classifications
Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05785117
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05785117 through Pure Global AI's free database. This phase not specified trial is sponsored by Rana Elbanna and is currently Recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.